MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Loading filters…
Showing 38 trials for C. difficile
VE303 for Prevention of Recurrent Clostridioides Difficile InfectionPhase 3Recruiting
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection RecurrenceClostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceCDIC. Diff InfectionRecurrent Clostridium Difficile InfectionC.Difficile DiarrheaDiarrhea Infectious
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (…
Huntsville, United StatesEst. completion Jun 2027
View Trial →
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyPhase 2Recruiting
Clostridioides Difficile Infection
The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioid…
Phoenix, United StatesEst. completion Apr 20, 2027
View Trial →
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First RecurrencePhase 3Recruiting
Clostridioides Difficile Infection
The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatm…
Basel, SwitzerlandEst. completion Apr 1, 2027
View Trial →
Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)Recruiting
Clostridioides Difficile Infection
This study aims to evaluate the impact of diet on the gut microbiome in adults with Clostridioides difficile infection (…
Ann Arbor, United StatesEst. completion Dec 2027
View Trial →
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk PatientsPhase 1Recruiting
Clostridioides Difficile InfectionRecurrent Infection
Clostridioides difficile infection (CDI) is the leading cause of nosocomial diarrhea in Europe, with over 120,000 cases …
Annecy, FranceEst. completion Jan 7, 2028
View Trial →
An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon ResectionPhase 1Recruiting
Recurrent Clostridioides Difficile InfectionColonic Surgery
This Phase 1 pilot clinical trial that will evaluate the initial safety and feasibility of orally administered preparati…
Minneapolis, United StatesEst. completion Feb 18, 2027
View Trial →
Intestinal Microbiota Transplantation in Patients Undergoing Colon ResectionPhase 1Recruiting
Recurrent Clostridioides Difficile InfectionColonic Surgery
This is a single-center, open-label study for safety and feasibility of IMT in patients undergoing colonic surgery. Afte…
Minneapolis, United StatesEst. completion Sep 1, 2026
View Trial →
Vancomycin Taper to Prevent Recurrent Clostridioides DifficilePhase 3Recruiting
Clostridia Difficile Colitis
Indirect evidence from network meta-analyses of randomized controlled trials (RCTs) suggest that a pulse and taper (P-T)…
Montreal, CanadaEst. completion Jun 1, 2030
View Trial →
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative ColitisRecruiting
Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic Inflammatory Bowel Disease characterized by chronic inflammation of the colon. Comp…
Paris, FranceEst. completion Jun 2029
View Trial →
Secondary Prevention of Clostridioides Difficile Using VancomycinPhase 2Recruiting
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
Re-exposure to systemic antibiotics (i.e., antibiotics absorbed into the bloodstream) is common after a Clostridioides d…
Montreal, CanadaEst. completion Oct 1, 2028
View Trial →
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.Recruiting
Clostridioides Difficile Infection Recurrence
Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "C…
Atlanta, United StatesEst. completion Oct 15, 2026
View Trial →
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis PopulationPhase 1Recruiting
Ulcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection
This is a multi-centre, randomised controlled trial comparing fecal microbiota transplantation to placebo in an expanded…
Calgary, CanadaEst. completion Mar 1, 2028
View Trial →
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderPhase 3Recruiting
Clostridioides Difficile Associated Disease
The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile…
Athens, United StatesEst. completion Dec 11, 2028
View Trial →
FMT Capsules for rCDIPhase 3Recruiting
Clostridioides Difficile Infection RecurrenceFMT
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Helsinki, FinlandEst. completion Dec 31, 2029
View Trial →
Changes in Recipients Gut Microbiota After Fecal Microbiota TransplantationRecruiting
Clostridioides Difficile Infection Recurrence
Clostridioides difficile infection (CDI) is the most common cause of nosocomial diarrhea, and the most common health care-…
Roma, ItalyEst. completion Feb 14, 2027
View Trial →
FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential ApproachPhase 1Recruiting
Clostridium DifficileUlcerative Colitis
Clostridioides difficile infection (CDI) is the most frequent cause of infectious diarrhea in hospitalized patients and …
Rome, ItalyEst. completion Sep 24, 2026
View Trial →
Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides DifficileRecruiting
C. Difficile
Clostridioides difficile (C. difficile) is the most common healthcare-associated pathogen, causing \>500,000 infections …
Boston, United StatesEst. completion Jun 1, 2025
View Trial →
Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial ClearanceRecruiting
Clostridium Difficile Infections
Clostridioides difficile (formerly Clostridium) is a bacterium found in the form of spores (resistance form) in the envi…
Paris, FranceEst. completion Nov 17, 2026
View Trial →
Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium DifficileRecruiting
Clostridium Difficile Infection RecurrenceClostridium Difficile Infection
The purpose of this study is to see if stool transplant performed by colonoscopy is effective at treating recurrent Clos…
Worcester, United StatesEst. completion Jan 16, 2028
View Trial →
LMN-201 for Prevention of C. Difficile Infection RecurrencePhase 2Recruiting
Clostridioides Difficile Infection
This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnos…
Escondido, United StatesEst. completion Jun 1, 2027
View Trial →
← PreviousPage 1 of 2Next →
Recruitment Status